Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Therapeutic Solutions International, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | Security Type | | Security Class Title | | Fee Calculation or Carry Forward Rule | | Amount Registered(1) | | Proposed Maximum Offering Price Per Unit(2) | | Maximum Aggregate Offering Price(2) | | Fee Rate | | Amount of Registration Fee(3) | |
Newly Registered Securities | |
Fees to be Paid | | Common Stock | | Common stock issuable upon the conversion of Series B Convertible Preferred Stock | | 457(o) | | N/A | | N/A | | $ | 9,219,567.99 | | $ | 0.0001476 per $1.00 | | $ | 1,360.81 | |
Fees Previously Paid | | N/A | | N/A | | N/A | | N/A | | N/A | | | N/A | | | N/A | | $ | 0 | |
| | Total Offering Amounts | | | | $ | 9,219,567.99 | | | | | $ | 1,360.81 | |
| | Total Fees Previously Paid | | | | | | | | | | $ | 0 | |
| | Total Fee Offsets | | | | | | | | | | $ | 0 | |
| | Net Fee Due | | | | | | | | | | $ | 1,360.81 | |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover additional securities that may be offered or issued to prevent dilution resulting from splits, dividends or similar transactions. |
| |
(2) | Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) and (g) under the Securities Act, based on the average of the high and low prices reported for the shares of Common Stock as reported on the OTC Markets on January 12, 2024. |
| |
(3) | Calculated pursuant to Rule 457(o) promulgated under the Securities Act, as amended. |